These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28416644)

  • 1. Evaluation of Different Estimation Methods for Accuracy and Precision in Biological Assay Validation.
    Yu B; Yang H
    PDA J Pharm Sci Technol; 2017; 71(4):297-305. PubMed ID: 28416644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring precision in bioassays: Rethinking assay validation.
    Fay MP; Sachs MC; Miura K
    Stat Med; 2018 Feb; 37(4):519-529. PubMed ID: 29052234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and in-house validation of a microbiological assay for determination of cefepime in injectable preparations.
    Souza MJ; Kulmann RR; Silva LM; Nogueira DR; Zimmermann ES; Schmidt CA
    J AOAC Int; 2006; 89(5):1367-72. PubMed ID: 17042189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Method for Qualification of a Potency Assay through Partial Computer Simulation.
    Novick S; Sondag P; Schofield T; Miller K
    PDA J Pharm Sci Technol; 2018; 72(3):249-263. PubMed ID: 29444993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of methods to handle skew distributed cost variables in the analysis of the resource consumption in schizophrenia treatment.
    Kilian R; Matschinger H; Löeffler W; Roick C; Angermeyer MC
    J Ment Health Policy Econ; 2002 Mar; 5(1):21-31. PubMed ID: 12529567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties.
    Winter J; Barbin K; Bacci C; Bunte T
    J Pharm Biomed Anal; 2011 Jan; 54(1):81-6. PubMed ID: 20828971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioassays for the characterisation and control of therapeutic cytokines; determination of potency.
    Thorpe R; Wadhwa M; Page C; Mire-Sluis A
    Dev Biol Stand; 1999; 97():61-71. PubMed ID: 10463531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioassay from two parabolas.
    Moussa MA
    Comput Biol Med; 1993 Jan; 23(1):69-76. PubMed ID: 8467640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons of outlier tests for potency bioassays.
    Sondag P; Zeng L; Yu B; Yang H; Novick S
    Pharm Stat; 2020 May; 19(3):230-242. PubMed ID: 31762118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of in vitro potency assays for tetanus immunoglobulin.
    Gross S; Volkers P; Eckert-Ziem M; Kuschel S; Schäffner G
    Pharmeuropa Bio; 2006 Nov; 2006(1):1-6. PubMed ID: 17270126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A receptor-binding-based bioassay to determine the potency of a plasmid biopharmaceutical encoding VEGF-C.
    Waerner T; Girsch T; Varga S; Huang L; Gornikiewicz A; Loeber G
    Anal Bioanal Chem; 2007 Dec; 389(7-8):2109-13. PubMed ID: 17957358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parallelism in practice: approaches to parallelism in bioassays.
    Fleetwood K; Bursa F; Yellowlees A
    PDA J Pharm Sci Technol; 2015; 69(2):248-63. PubMed ID: 25868991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioassay battery interlaboratory investigation of emerging contaminants in spiked water extracts - Towards the implementation of bioanalytical monitoring tools in water quality assessment and monitoring.
    Di Paolo C; Ottermanns R; Keiter S; Ait-Aissa S; Bluhm K; Brack W; Breitholtz M; Buchinger S; Carere M; Chalon C; Cousin X; Dulio V; Escher BI; Hamers T; Hilscherová K; Jarque S; Jonas A; Maillot-Marechal E; Marneffe Y; Nguyen MT; Pandard P; Schifferli A; Schulze T; Seidensticker S; Seiler TB; Tang J; van der Oost R; Vermeirssen E; Zounková R; Zwart N; Hollert H
    Water Res; 2016 Nov; 104():473-484. PubMed ID: 27585427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a quantitative cell-based bioassay for comparing the pharmacokinetic profiles of two recombinant erythropoietic proteins in serum.
    Wei X; Grill DS; Heatherington AC; Swanson SJ; Gupta S
    J Pharm Biomed Anal; 2007 Jan; 43(2):666-76. PubMed ID: 16971087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory comparison of in vitro bioassays for screening of endocrine active chemicals in recycled water.
    Mehinto AC; Jia A; Snyder SA; Jayasinghe BS; Denslow ND; Crago J; Schlenk D; Menzie C; Westerheide SD; Leusch FD; Maruya KA
    Water Res; 2015 Oct; 83():303-9. PubMed ID: 26177482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision, accuracy, and data acceptance criteria in biopharmaceutical analysis.
    Karnes HT; March C
    Pharm Res; 1993 Oct; 10(10):1420-6. PubMed ID: 8272402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of several methods for analyzing censored data.
    Hewett P; Ganser GH
    Ann Occup Hyg; 2007 Oct; 51(7):611-32. PubMed ID: 17940277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Lack-of-Fit Assessment as a System Suitability Test for Potency Assays.
    Li R; Cai W; Zocher M
    PDA J Pharm Sci Technol; 2017; 71(5):368-378. PubMed ID: 28624777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.